Walt Addison Linscott insider trades

Open-market stock purchases and sales by Walt Addison Linscott, Chief Operating Officer at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Jul 21, 2015.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +40%.

Recent trades

DateStockTradeValue
Dec 22, 2025INDP Indaptus Therapeutics, IncBought (not open market)$110K

Companies traded

  • INDP Indaptus Therapeutics, Inc: 1 buy, last Dec 22, 2025
  • NTEC Intec Pharma Ltd: other filings, last Sep 16, 2020
  • COCP Cocrystal Pharma, Inc: other filings, last Jul 21, 2015

Get free alerts when Walt Addison Linscott files a new trade →